<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Perm Medical Journal</journal-id><journal-title-group><journal-title xml:lang="en">Perm Medical Journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Пермский медицинский журнал (сетевое издание "Perm medical journal")</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0136-1449</issn><issn publication-format="electronic">2687-1408</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">7229</article-id><article-id pub-id-type="doi">10.17816/pmj346%p</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">THE POSSIBILITY OF USING THE MELD SCALE FOR DETERMINING SEVERITY OF LIVER CIRRHOSISTHE</article-title><trans-title-group xml:lang="ru"><trans-title>THE POSSIBILITY OF USING THE MELD SCALE FOR DETERMINING SEVERITY OF LIVER CIRRHOSIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bulatova</surname><given-names>Irina</given-names></name><name xml:lang="ru"><surname>Булатова</surname><given-names>Ирина Анатольевна</given-names></name></name-alternatives><email>bula.1977@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8255-088X</contrib-id><contrib-id contrib-id-type="spin">2581-7279</contrib-id><name-alternatives><name xml:lang="en"><surname>Paducheva</surname><given-names>Svetlana</given-names></name><name xml:lang="ru"><surname>Падучева</surname><given-names>Светлана Вячеславовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>ассистент кафедры клиническая лабораторная диагнстика ФДПО</p></bio><email>paducheva_sv@mail.ru</email><uri>https://elibrary.ru/author_profile.asp?id=953430</uri><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shchekotova</surname><given-names>Alevtina</given-names></name><name xml:lang="ru"><surname>Щекотова</surname><given-names>Алевтина Павловна</given-names></name></name-alternatives><email>al_shchekotova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shchekotova</surname><given-names>Irina</given-names></name><name xml:lang="ru"><surname>Щекотова</surname><given-names>Ирина Владимировна</given-names></name></name-alternatives><email>shchekotirina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution></institution></aff><aff-alternatives id="aff2"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Пермский государственный медицинский университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2017</year></pub-date><volume>34</volume><issue>6</issue><issue-title xml:lang="en">VOL 34, NO6 (2017)</issue-title><issue-title xml:lang="ru">ТОМ 34, №6 (2017)</issue-title><history><date date-type="received" iso-8601-date="2017-12-02"><day>02</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Bulatova I., Paducheva S., Shchekotova A., Shchekotova I.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Булатова И.А., Падучева С.В., Щекотова А.П., Щекотова И.В.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Bulatova I., Paducheva S., Shchekotova A., Shchekotova I.</copyright-holder><copyright-holder xml:lang="ru">Булатова И.А., Падучева С.В., Щекотова А.П., Щекотова И.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://permmedjournal.ru/PMJ/article/view/7229">https://permmedjournal.ru/PMJ/article/view/7229</self-uri><abstract xml:lang="en"><p>Objective: to Study the possibility of using the MELD scale to determine the severity of CKD and to determine its diagnostic capabilities.Methods:we Examined 30 patients with CKD, of which 15 patients were compensated stage of CKD (grade a+) Child-Pugh and 15 people with decompensated cirrhosis (class C). In the blood was evaluated the concentration of total bilirubin and creatinine were calculated INR and the MELD index.Results: the Calculated MELD index using the indicators of total bilirubin, creatinine and INR increased with the progression of CKD 5 in the stage of compensation to 26 in decompensated stage (p&lt;0.001) and directly correlated with the severity of cirrhosis, assessed by Child-Pugh (rs=0,64; p=0.005). The threshold index value of MELD for the differentiation of compensated stage decompensated CPU from equal to 11.Conclusions:MELD Calculated index allows to differentiate the degree of severity of CKD with a sensitivity of 73.3% and a specificity of 84.6%. When the value of the index, MELD less than or equal to 11 are diagnosed with compensated stage of the CPU, a value of more than 11 sets of decompensated cirrhosis.Ваши исправления помогают повысить качество машинного переводаСообщить об ошибке</p></abstract><trans-abstract xml:lang="ru"><p>Objective: to Study the possibility of using the MELD scale to determine the severity of CKD and to determine its diagnostic capabilities.</p>
<p>Methods:we Examined 30 patients with CKD, of which 15 patients were compensated stage of CKD (grade a+) Child-Pugh and 15 people with decompensated cirrhosis (class C). In the blood was evaluated the concentration of total bilirubin and creatinine were calculated INR and the MELD index.</p>
<p>Results: the Calculated MELD index using the indicators of total bilirubin, creatinine and INR increased with the progression of CKD 5 in the stage of compensation to 26 in decompensated stage (p&lt;0.001) and directly correlated with the severity of cirrhosis, assessed by Child-Pugh (rs=0,64; p=0.005). The threshold index value of MELD for the differentiation of compensated stage decompensated CPU from equal to 11.</p>
<p>Conclusions:MELD Calculated index allows to differentiate the degree of severity of CKD with a sensitivity of 73.3% and a specificity of 84.6%. When the value of the index, MELD less than or equal to 11 are diagnosed with compensated stage of the CPU, a value of more than 11 sets of decompensated cirrhosis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Цирроз печени</kwd><kwd>степень тяжести цирроза</kwd><kwd>шкала MELD</kwd><kwd>шкала Child-Pugh</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1.	Бессонова Е.Н., Кокина К. Ю. Современные возможности оценки тяжести состояния и прогноза жизни больных циррозом печени в терминальной стадии. Клинические перспективы гастроэнтерологии, гепатологии. 2012; 5: 19-26.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2.	Власов В. В. Эффективность диагностических исследований. М.: Медицина 1988; 256.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3.	Краснов О.А., Павленко В.В., Краснов К.А., Краснов А.О., Пельц В.А., Старцев А.Б., Аминов И.Х., Сохарев А.С., Керопян С.Е. Современные методы оценки функционального резерва печени в резекуионной хирургии органаю Медицина и образование в Сибири. 2014; 6: http://www.ngmu.ru/cozo/mos/article/text_full.php?id=1603].</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4.	Кучерявый Ю.А., Стукова Н.Ю., Ахтаева М.Л. Хронический гепатит, цирроз печени и гепатоцеллюлярная карцинома - звенья одной цепи. Клинические перспективы гастраэнтерологии и гепатологии. 2012; 5: 3-12.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5.	Лечение осложнений цирроза печени (методические рекомендации для врачей). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2009; 1(19): 78-86.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6.	Тайшин Д.О., Солдатова Г.С. Анализ прогностических шкал для оценки исхода цирроза печени. Вестник НГУ. Серия: Биология, клиническая медицина. 2014; 2(12).</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7.	Flodén A. Calculation and comparison of the model for end-stage liver disease (MELD) score in patients accepted for liver transplantation in 1999 and 2004. Transplant Proc. 2007; 39: 385–386.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8.	Huo T.I. The sequential changes of the model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular carcinoma undergoing locoregional therapy. J Clin Gastroenterol. 2006; 40(6): 543-50.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9.	Kamath P.S., Wiesner R.H., Malinchoc M. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33(2): 464–70.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10.	Lucey M.R., Brown K.A., Everson G.T. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation. 1998; 66 (7): 956–62.</mixed-citation></ref></ref-list></back></article>
